<DOC>
	<DOCNO>NCT02856451</DOCNO>
	<brief_summary>A case series analysis encephalitis event report Sponsor patient treat nivolumab ass risk factor outcomes immune-mediated encephalitis .</brief_summary>
	<brief_title>Risk Factors Outcomes Immune-Mediated Encephalitis Following Exposure Nivolumab</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Nivolumab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Moderate , severe , lifethreatening fatal encephalitis event occur patient treat nivolumab report Sponsor Encephalitis case identify literature review report Sponsor Encephalitis case identify companysponsored observational study secondary data collection Spontaneous report submit directly Sponsor Other protocol define inclusion/exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>